![The Treatment That Could Crush Covid]()
by admin | Aug 14, 2020 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Early trials show signaling cells eliminate the virus, calm the immune response and repair tissue damage. By Kevin Kimberlin – Wall Street Journal More than 500 clinical trials are under way world-wide in the race to find an effective treatment for Covid-19....
![The Treatment That Could Crush Covid]()
by admin | Jul 28, 2020 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Durham, NC – A new study released today in STEM CELLS Translational Medicine shows promise of a major breakthrough in healing chronic foot ulcers resulting from diabetes. The study, by researchers at the University of California, Davis, is the first to demonstrate how...
by admin | Jul 23, 2020 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Durham, NC – A new platform reported on today in STEM CELLS Translational Medicine (SCTM) will enable long-term tracking of cardiomyocytes produced from induced pluripotent stem cells (iPSCs) after implantation into the heart. This non-invasive strategy, created by...
![The Treatment That Could Crush Covid]()
by admin | Jul 22, 2020 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Researchers will use ‘mini lungs in a dish’ to test promising drug candidates Sanford Burnham Prebys Medical Discovery Institute has received an award from the California Institute for Regenerative Medicine (CIRM) to advance promising drug candidates for...
![The Treatment That Could Crush Covid]()
by admin | Jul 14, 2020 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
PITTSBURGH – The National Institutes of Health (NIH) has renewed a five-year grant for $5 million for the Alliance for Regenerative Rehabilitation and Training (AR3T) to continue its work expanding scientific knowledge, expertise and methodologies focused on science...
![The Treatment That Could Crush Covid]()
by admin | Jul 14, 2020 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
BOCA RATON, Fla.–(BUSINESS WIRE)–Akron Biotechnology, which develops and manufactures cGMP-compliant cytokines and other ancillary materials to enable cell and gene therapy development and commercialization, today announced that it has submitted Type II...
